Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL28402873 | 1.00 | ALDH1A1 (0.86) | — | |
| Alcohol SCHEMBL452225 | 1.00 | — | — | |
| Alcohol SCHEMBL15348581 | 1.00 | ALDH1A1 (0.86) | — | |
| Alcohol SCHEMBL28515749 | 1.00 | ALDH1A1 (0.86) | — | |
| Alcohol SCHEMBL7865660 | 1.00 | ALDH1A1 (0.86) | — | |
| Alcohol SCHEMBL4485375 | 1.00 | — | — | |
| Alcohol SCHEMBL5314318 | 1.00 | ALDH1A1 (0.86) | — | |
| Alcohol SCHEMBL175188 | 1.00 | — | — | |
| Alcohol SCHEMBL9815312 | 1.00 | — | — | |
| Alcohol SCHEMBL9225033 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117026644-B | Continuous fiber reinforced polyurethane composite material and preparation method thereof | 河北聚久复合材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-116337842-B | Three-dimensional SERS substrate for detecting Fubi-mei and preparation method thereof | 中国科学院苏州生物医学工程技术研究所 | 2025-06-10 | — | — | CN | claimed |
| CN-117026644-A | Continuous fiber reinforced polyurethane composite material and preparation method thereof | 河北聚久复合材料有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-104513274-B | A kind of chiral pincerlike compounds of P and its palladium complex | 上海交通大学 | 2018-07-03 | — | — | CN | claimed |
| CN-108190939-A | A kind of preparation method of hierarchical structure photonic crystal | 常州市沃兰特电子有限公司 | 2018-06-22 | — | — | CN | claimed |
| CN-104513274-A | P chiral pincer compound and palladium coordination compound thereof | UNIV SHANGHAI JIAOTONG | 2015-04-15 | — | — | CN | claimed |
| US-20150065699-A1 | GINSENOSIDE C-K POLYMORPHIC COMPOUNDS AND METHOD FOR PREPARING SAME | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2015-03-05 | — | — | US | claimed |
| EP-2835378-A1 | GINSENOSIDE C-K POLYMORPHIC COMPOUNDS AND METHOD FOR PREPARING SAME | Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) | 2015-02-11 | — | — | EP | claimed |
| EP-2069374-B1 | CRYSTALLINE SOLVATES OF (1S)-1,5-ANHYDRO-1-C-(3-((PHENYL) METHYL) PHENYL)-D-GLUCITOL DERIVATIVES WITH ALCOHOLS AS SGLT2 INHIBITORS FOR THE TREATMENT OF DIABETES | ASTRAZENECA AB (SE) | 2014-07-30 | — | — | EP | claimed |
| CN-103360441-A | Ginsenoside C-K compound polycrystal and preparation method thereof | ZHEJIANG HISUN PHARM CO LTD | 2013-10-23 | — | — | CN | claimed |
| EP-3976628-B1 | NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF | SAGE THERAPEUTICS LLC (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20250250296-A1 | NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF | SAGE THERAPEUTICS, INC. | 2025-08-07 | — | — | US | disclosed |
| US-20250236639-A1 | NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF | SAGE THERAPEUTICS, INC. | 2025-07-24 | — | — | US | disclosed |
| CN-117026644-B | Continuous fiber reinforced polyurethane composite material and preparation method thereof | 河北聚久复合材料有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120000789-A | Use of TIN2 gene inhibitor in preparation of retinopathy treatment product or anti-aging product | 上海市第一人民医院 | 2025-05-16 | — | — | CN | disclosed |
| EP-0621269-A1 | Alkyl substituted nitroimidazole acetic acids | ELI LILLY AND COMPANY (US) | 1994-10-26 | — | — | EP | disclosed |
| EP-0610448-A1 | PEPTIDE LIBRARY AND SCREENING METHOD | AFFYMAX TECHNOLOGIES N.V. (AN) | 1994-08-17 | — | — | EP | disclosed |
| EP-0573271-A1 | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1993-12-08 | — | — | EP | disclosed |
| WO-1993008278-A1 | PEPTIDE LIBRARY AND SCREENING METHOD | AFFYMAX TECHNOLOGIES N.V. (AN) | 1993-04-29 | — | — | WO | disclosed |
| US-4594424-A | Mixture with a solvent and a alkali metal halide | UBE INDUSTRIES, LTD. (JP) | 1986-06-10 | — | — | US | disclosed |